---
title: "Shanghai Microport EP Medtech Co., Ltd. (688351.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688351.SH.md"
symbol: "688351.SH"
name: "Shanghai Microport EP Medtech Co., Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-19T18:44:41.314Z"
locales:
  - [en](https://longbridge.com/en/quote/688351.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688351.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688351.SH.md)
---

# Shanghai Microport EP Medtech Co., Ltd. (688351.SH)

## Company Overview

Shanghai MicroPort EP MedTech Co., Ltd. engages in the research, development, production, and sale of medical devices in the field of electrophysiological interventional diagnosis and ablation therapy in China and internationally. The company offers cardiac ablation catheters, diagnostic catheters, and system navigational solutions; access conventional solutions; cryoablation solutions; and robotic magnetic navigation solutions. It also exports its products to France, Italy, Bulgaria, Brazil, and Thailand.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.everpace.com](https://www.everpace.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: C (0.40)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 37 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 13.61% |  |
| Net Profit YoY | -5.28% |  |
| P/B Ratio | 6.83 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 12332050703.73 |  |
| Revenue | 485895000.86 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 3.49% | C |
| Profit Margin | 12.81% | B |
| Gross Margin | 55.80% | B |
| Revenue YoY | 13.61% | B |
| Net Profit YoY | -5.28% | C |
| Total Assets YoY | 4.20% | C |
| Net Assets YoY | 2.55% | C |
| Cash Flow Margin | 54.59% | C |
| OCF YoY | 13.61% | B |
| Turnover | 0.25 | D |
| Gearing Ratio | 9.56% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shanghai Microport EP Medtech Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "13.61%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-5.28%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "6.83",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "12332050703.73",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "485895000.86",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "3.49%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "12.81%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "55.80%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "13.61%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-5.28%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "4.20%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "2.55%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "54.59%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "13.61%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.25",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "9.56%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 197.16 | 49/64 | 214.84 | 197.16 | 149.47 |
| PB | 6.80 | 60/64 | 6.33 | 6.08 | 5.54 |
| PS (TTM) | 25.25 | 63/64 | 24.84 | 23.98 | 22.45 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-11T16:00:00.000Z

Total Analysts: **7**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 5 | 71% |
| Overweight | 1 | 14% |
| Underweight | 1 | 14% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 26.10 |
| Highest Target | 31.00 |
| Lowest Target | 9.20 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688351.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688351.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688351.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**